The matricellular protein CTGF is known to be upregulated in several glioblastoma models in mice [135] and also in human brain tumors [136], it is mainly produced by activated astrocytes and represents an attractive target for the treatment of glioblastoma [137]. This evidence concerns the gene CCN2 and glioblastoma.